Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma

被引:284
作者
Meitar, D
Crawford, SE
Rademaker, AW
Cohn, SL
机构
[1] CHILDRENS MEM HOSP,DIV HEMATOL ONCOL,DEPT PEDIAT,CHICAGO,IL 60614
[2] CHILDRENS MEM HOSP,DEPT PATHOL,CHICAGO,IL 60614
[3] NORTHWESTERN UNIV,SCH MED,ROBERT LURIE CANC CTR,BIOMETRY SECT,CHICAGO,IL
关键词
D O I
10.1200/JCO.1996.14.2.405
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To determine if the clinical outcome of children with neuroblastoma (NB) is correlated with the degree of tumor neovascularization and to assess the relationship of stage, N-myc copy number, and histology to angiogenesis. Materials and Methods: The vascularity of primary untreated NB from 50 patients diagnosed at a single institution between 1984 and 1994 wets evaluated, An image processor was used to analyze the tumor tissue area for each histologic slide of tumor, and a vascular index (VI) was calculated, where VI = total number of vessels/mm(2) of tissue area, Tumors were classified histologically according to the criteria of Shimada et al (J Natl Cancer Inst 73:405-416, 1984), and N-myc copy number was determined by Southern blot analysis. Results: We found that higher VI (> 4.0) in NE strongly correlated with widely disseminated disease (P = .006) and poor survival (P < .0001). VI more than 4.0 was also statistically associated with N-myc amplification (P = .02) and unfavorable histology (P = .02), Univariate analysis demonstrated that disease stage, tumor histology, and N-myc copy number were also predictive of outcome, Cox regression analysis showed that VI provided independent prognostic information. Conclusion: Our studies indicate that angiogenesis may play an important role in determining the biologic behavior of NB. Antiangiogenic therapy may prove to be effective in the treatment of children with highly vascular, widely disseminated NB. (C) 1996 by American Society of Clinical Oncology.
引用
收藏
页码:405 / 414
页数:10
相关论文
共 69 条
[1]   THE RELATIONSHIP OF ANGIOGENESIS TO BIOLOGICAL-ACTIVITY IN HUMAN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK [J].
ALBO, D ;
GRANICK, MS ;
JHALA, N ;
ATKINSON, B ;
SOLOMON, MP .
ANNALS OF PLASTIC SURGERY, 1994, 32 (06) :588-594
[2]   N-MYC AMPLIFICATION CAUSES DOWN-MODULATION OF MHC CLASS-I ANTIGEN EXPRESSION IN NEUROBLASTOMA [J].
BERNARDS, R ;
DESSAIN, SK ;
WEINBERG, RA .
CELL, 1986, 47 (05) :667-674
[3]   SEQUENCE-SPECIFIC DNA-BINDING BY THE C-MYC PROTEIN [J].
BLACKWELL, TK ;
KRETZNER, L ;
BLACKWOOD, EM ;
EISENMAN, RN ;
WEINTRAUB, H .
SCIENCE, 1990, 250 (4984) :1149-1151
[4]   MAX - A HELIX-LOOP-HELIX ZIPPER PROTEIN THAT FORMS A SEQUENCE-SPECIFIC DNA-BINDING COMPLEX WITH MYC [J].
BLACKWOOD, EM ;
EISENMAN, RN .
SCIENCE, 1991, 251 (4998) :1211-1217
[5]   CLINICAL-PROGRESS IN NEUROBLASTOMA [J].
BONILLA, MA ;
CHEUNG, NKV .
CANCER INVESTIGATION, 1994, 12 (06) :644-653
[6]   TRK AND RET PROTOONCOGENE EXPRESSION IN HUMAN NEUROBLASTOMA SPECIMENS - HIGH-FREQUENCY OF TRK EXPRESSION IN NON-ADVANCED STAGES [J].
BORRELLO, MG ;
BONGARZONE, I ;
PIEROTTI, MA ;
LUKSCH, R ;
GASPARINI, M ;
COLLINI, P ;
PILOTTI, S ;
RIZZETTI, MG ;
MONDELLINI, P ;
DEBERNARDI, B ;
DIMARTINO, D ;
GARAVENTA, A ;
BRISIGOTTI, M ;
TONINI, GP .
INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (04) :540-545
[7]   MICROVESSEL QUANTITATION AND PROGNOSIS IN INVASIVE BREAST-CARCINOMA [J].
BOSARI, S ;
LEE, AKC ;
DELELLIS, RA ;
WILEY, BD ;
HEATLEY, GJ ;
SILVERMAN, ML .
HUMAN PATHOLOGY, 1992, 23 (07) :755-761
[8]  
BOUCK N, 1990, CANCER CELL-MON REV, V2, P179
[9]  
BOWMAN LC, 1991, J CLIN ONCOL, V9, P1559
[10]  
BRESLOW N, 1971, CANCER RES, V31, P2098